Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH)

Market Cap	348.94M
Revenue (ttm)	364.55M
Net Income (ttm)	31.15M
Shares Out	141.84M
EPS (ttm)	0.22
PE Ratio	11.20
Forward PE	n/a
Dividend	0.11 (4.40%)
Ex-Dividend Date	Jun 24, 2024

Volume	19,000
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	2.260 - 3.180
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2024

About YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, manufactures and trades in generic drugs. The company operates through three segments: Manufacturing, Trading, and Investment Holding. It manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. The company also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-cou...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,369
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2023, YSPSAH's revenue was 355.00 million, an increase of 6.21% compared to the previous year's 334.25 million. Earnings were 37.32 million, an increase of 8.27%.